What is quantum computing? That’s a question still being asked by much of the world’s C-suite. But here at CC our multidisciplinary teams of physicists, engineers and designers are already helping to plot a credible pathway for a future powered by quantum technologies
What can quantum computing and quantum technology do for the pharma and life sciences industry? Elizabeth Thomas has conferred with Cambridge Consultants’ quantum experts and shares her insights into how organisations can start implementing an action plan.
Symon Cotton has been reflecting on the future of the genomics ecosystem. Here he discusses how genomics – plus the emergence of panomics and long read sequencing – could inform clinical practice and patient care.
Not everyone knows how to embark on the road to a new market breakthrough – or has the confidence to overcome natural hesitancy. At CC, we believe in the design thinking approach known as DVF (Desirability, Viability, Feasibility).
Swiss company Qnami, a leader in quantum sensing technology, tasked us with identifying potential applications in the biomedical area where NV magnetometry could provide clinical value and open new commercial avenues.
The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. Symon Cotton, Head of Life Sciences takes a look at the opportunities on offer for companies working in this dynamic field.